摘要
16例经全反式维甲酸治疗达完全缓解后进行了骨髓移植治疗的急性早幼粒细胞性白血病,其中8例为异基因骨髓移植,8例为自体骨髓移植。8例Alo-BMT的6例存活(53+、52+、15+、10+、7+及3+月),2例病人死于急性移植物抗宿主病(1+月及2+月)。8例ABMT病人有6例存活(59+、45+、40+、35+、32+及29+月),1例病人复发(23+月),另1例移植早期死亡(1+)月。
Sixteen patients with acute myeloid leukemia M3(AML M 3) in first complete remission after treatment of all trans retinoic acid were treated by Allo BMT(n=8) and ABMT(n=8). After Allo BMT, six patients are alive(53 +,52 +,15 +,10 +,7 + and 3 + months, respectively), two patients died of GVHD(1 +and 2 + months). In ABMT, six patients are alive(59 +,45 +,40 +,35 +,32 + and 29 + months respectively), one patient relapsed and died (23 + months), another died early (1 month). We concluded that Allo BMT and ABMT are effective in treating patients with AML M 3 after the first complete remission with all trans retinoic acid.
出处
《白血病》
1996年第1期14-17,共4页
关键词
骨髓移植
全反式维甲酸
急性
白血病
Allogeneic bone marrow transplantation(Allo BMT) Autologous bone marrow Transplantation(ABMT) Acute myeloid leukemia M3(AML M 3) All trans Retionic acid